Albumin Human

DRUG4 trials

Sponsors

Jordi Carratala, Rush University Medical Center, American Burn Association, Egymedicalpedia

Conditions

Burn InjuryCirrhosis, LiverCommunity-acquired PneumoniaFluid OverloadHypoalbuminemiaSeptic ShockVolume Overload

Phase 3

Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.

TerminatedNCT04071041

Jordi CarratalaCommunity-acquired Pneumonia, Hypoalbuminemia

Start: 2019-10-31End: 2021-10-31Updated: 2023-01-31

Phase 4

Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients

TerminatedNCT04216784

Rush University Medical CenterCirrhosis, Liver, Fluid Overload, Volume Overload

Start: 2019-12-19End: 2024-04-01Updated: 2025-09-16

Unknown Phase

The Acute Burn ResUscitation Multicenter Prospective Trial

RecruitingNCT04356859

American Burn AssociationBurn Injury

Start: 2021-04-22End: 2025-09-30Target: 400Updated: 2024-02-01

Effect of Early Administration of Albumin 20% Versus Crystalloid

RecruitingNCT06370078

EgymedicalpediaSeptic Shock

Start: 2024-06-01End: 2024-11-30Target: 46Updated: 2024-06-06

Related Papers

Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial-a trial protocol.

2020-08-204 citations